A patient without apparent immunodeficiency experienced a late relapse of Ebola virus disease with subsequent transmission causing 91 secondary cases. Such late relapse raises concerns regarding control of this disease.
Outbreaks in Guinea, Congo — CDC alerts U.S. providers
March 17, 2021
An emerging Ebola outbreak in Guinea may have been sparked by a survivor of the historic West African outbreak of 2013-2016. That means the virus would have had to incubate in the index case, without replicating enough to cause acute disease, for at least five years.
Experts from the National Ebola Training and Education Center urge healthcare systems to adopt processes in line with “Identify, Isolate, and Inform,” a process for quickly identifying and managing cases of infectious disease in a way that minimizes the risk for subsequent transmissions.
In a scientific/public health triumph, the first vaccine for the prevention of Ebola virus infection has been approved. If administered prior to 10 days after exposure, its protective efficacy is 100%.
In addition to issues of malaria, vaccination, and trauma in travelers, viral diseases and the management of diarrhea were key topics at the biannual meeting of the International Society of Travel Medicine in Barcelona, Spain, during May 2017.